These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14978457)

  • 21. [Depression and anxiety. Broad spectrum SSRI to control both].
    MMW Fortschr Med; 2001 Sep; 143(35-36):55-6. PubMed ID: 11584534
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of non-cognitive symptoms in dementia.
    Karlsson I
    Acta Neurol Scand Suppl; 1996; 168():93-5. PubMed ID: 8997427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy.
    Stahl SM
    J Clin Psychiatry; 1999 Apr; 60(4):213-4. PubMed ID: 10221279
    [No Abstract]   [Full Text] [Related]  

  • 24. [Individualized treatment with antidepressants].
    Köhler S; Arndt A; Sterzer P; Bschor T
    Fortschr Neurol Psychiatr; 2013 Feb; 81(2):104-16; quiz 117-8. PubMed ID: 23412962
    [No Abstract]   [Full Text] [Related]  

  • 25. The risks and benefits of antidepressants to treat pediatric-onset depression and anxiety disorders: a developmental perspective.
    Leckman JF
    Psychother Psychosom; 2013; 82(3):129-31. PubMed ID: 23548739
    [No Abstract]   [Full Text] [Related]  

  • 26. Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients.
    Cassano GB; Puca F; Scapicchio PL; Trabucchi M;
    J Clin Psychiatry; 2002 May; 63(5):396-402. PubMed ID: 12019663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of new antidepressants in the treatment of anxiety/depressive disorders.
    Boerner RJ; Möller HJ
    Pharmacopsychiatry; 1999 Jul; 32(4):119-26. PubMed ID: 10505481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paxil (paroxetine) lifts depression, lowers associated anxiety symptoms.
    Adv Nurse Pract; 1997 Oct; 5(10):71. PubMed ID: 9459990
    [No Abstract]   [Full Text] [Related]  

  • 29. Treating comorbid depression and anxiety.
    Kuzel RJ
    J Fam Pract; 1996 Dec; 43(6 Suppl):S45-53. PubMed ID: 8969712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are SSRIs really more effective for anxious depression?
    Panzer MJ
    Ann Clin Psychiatry; 2005; 17(1):23-9. PubMed ID: 15941028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mental health care in Japan: recognition and treatment of depression and anxiety disorders.
    Tajima O
    J Clin Psychiatry; 2001; 62 Suppl 13():39-44; discussion 45-6. PubMed ID: 11434417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiety symptoms in elderly patients with depression: what is the best approach to treatment?
    Lenze EJ; Mulsant BH; Shear MK; Houck P; Reynolds III CF
    Drugs Aging; 2002; 19(10):753-60. PubMed ID: 12390052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality-of-life impairment in depressive and anxiety disorders.
    Rapaport MH; Clary C; Fayyad R; Endicott J
    Am J Psychiatry; 2005 Jun; 162(6):1171-8. PubMed ID: 15930066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.
    Bourin M
    Hum Psychopharmacol; 2003 Apr; 18(3):185-90. PubMed ID: 12672169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
    Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy in depressed children and adolescents.
    Taurines R; Gerlach M; Warnke A; Thome J; Wewetzer C
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance-P antagonists: a new treatment for depression?
    Nutt D
    Lancet; 1998 Nov; 352(9141):1644-6. PubMed ID: 9853433
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.